000 01755 a2200553 4500
005 20250514003453.0
264 0 _c20011101
008 200111s 0 0 eng d
022 _a0196-9781
024 7 _a10.1016/s0196-9781(01)00436-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIto, T
245 0 0 _aGI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity.
_h[electronic resource]
260 _bPeptides
_cJul 2001
300 _a1139-51 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmino Acid Sequence
650 0 4 _aAmylases
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCHO Cells
650 0 4 _aCells, Cultured
650 0 4 _aCricetinae
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGrowth Hormone
_xpharmacology
650 0 4 _aGrowth Hormone-Releasing Hormone
_xanalogs & derivatives
650 0 4 _aGuinea Pigs
650 0 4 _aHaplorhini
650 0 4 _aHumans
650 0 4 _aMolecular Sequence Data
650 0 4 _aPancreas
_xmetabolism
650 0 4 _aPeptides
_xchemistry
650 0 4 _aPituitary Gland
_xcytology
650 0 4 _aProtein Binding
650 0 4 _aRats
650 0 4 _aReceptors, Vasoactive Intestinal Peptide
_xagonists
650 0 4 _aSequence Homology, Amino Acid
650 0 4 _aTransfection
650 0 4 _aTumor Cells, Cultured
700 1 _aIgarashi, H
700 1 _aPradhan, T K
700 1 _aHou, W
700 1 _aMantey, S A
700 1 _aTaylor, J E
700 1 _aMurphy, W A
700 1 _aCoy, D H
700 1 _aJensen, R T
773 0 _tPeptides
_gvol. 22
_gno. 7
_gp. 1139-51
856 4 0 _uhttps://doi.org/10.1016/s0196-9781(01)00436-3
_zAvailable from publisher's website
999 _c11374009
_d11374009